HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaya Takahashi Selected Research

sampatrilat

4/2003Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaya Takahashi Research Topics

Disease

26Neoplasms (Cancer)
01/2020 - 11/2002
9Fibrosis (Cirrhosis)
01/2017 - 04/2003
7Heart Failure
11/2013 - 04/2003
6Breast Neoplasms (Breast Cancer)
05/2021 - 01/2011
6Milk Hypersensitivity (Milk Allergy)
08/2018 - 01/2015
6Myocardial Infarction
11/2013 - 08/2003
5Fatigue
09/2018 - 01/2005
5Cardiomyopathies (Cardiomyopathy)
01/2018 - 08/2003
5Lung Neoplasms (Lung Cancer)
10/2017 - 02/2007
5Hypersensitivity (Allergy)
10/2017 - 01/2014
5Glioma (Gliomas)
02/2017 - 02/2006
4Sleepiness
11/2021 - 01/2011
4Ischemia
07/2021 - 04/2006
3Brain Neoplasms (Brain Tumor)
11/2015 - 10/2012
3Neoplasm Metastasis (Metastasis)
05/2013 - 03/2011
3Glioblastoma (Glioblastoma Multiforme)
10/2012 - 02/2006
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2009 - 02/2007
3Disorders of Excessive Somnolence (Hypersomnia)
10/2006 - 06/2003
2Thrombocytopenia (Thrombopenia)
02/2022 - 11/2021
2Esophageal Neoplasms (Esophageal Cancer)
02/2022 - 12/2013
2Hemorrhage
07/2021 - 10/2014
2Infections
07/2021 - 05/2021
2Hypotension (Low Blood Pressure)
01/2020 - 07/2018
2Hyperoxia
04/2016 - 09/2007
2Mental Disorders (Mental Disorder)
01/2016 - 06/2014
2Cardiomegaly (Heart Hypertrophy)
06/2015 - 12/2003
2Hypertrophy
06/2015 - 07/2012
2Chronic Obstructive Pulmonary Disease (COPD)
04/2014 - 08/2011
2Necrosis
03/2014 - 07/2012
2Food Hypersensitivity (Food Allergy)
02/2014 - 01/2014
2Prostatic Neoplasms (Prostate Cancer)
05/2013 - 05/2013
2Nephrotic Syndrome (Syndrome, Nephrotic)
06/2012 - 01/2012
2Occupational Stress
04/2012 - 06/2007
2Urolithiasis
04/2012 - 01/2012
2Bacterial Meningitis
04/2012 - 01/2012
2Alcoholic Fatty Liver
12/2011 - 04/2011
2Fatty Liver
04/2011 - 07/2003
2Pain (Aches)
05/2009 - 10/2006
2Liver Cirrhosis (Hepatic Cirrhosis)
06/2007 - 08/2006
2Hypoxia (Hypoxemia)
08/2006 - 06/2003
2Infarction (Infarctions)
06/2006 - 02/2005
1Cytomegalovirus Infections (Inclusion Disease)
04/2022
1Acute Kidney Injury (Acute Renal Failure)
04/2022

Drug/Important Bio-Agent (IBA)

6APTIBA
02/2017 - 01/2013
6Proteins (Proteins, Gene)FDA Link
01/2017 - 05/2008
5AmidesIBA
02/2017 - 01/2013
5Protons (Proton)IBA
02/2017 - 01/2013
5ORALIT (ORS)IBA
03/2013 - 11/2006
4Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2010
4Biological ProductsIBA
01/2020 - 04/2011
4N-(4-aminophenethyl)spiroperidol (NAPS)IBA
01/2013 - 06/2003
3Tyrosine Kinase InhibitorsIBA
12/2018 - 07/2007
3Omalizumab (Xolair)FDA Link
08/2018 - 01/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 01/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2016 - 08/2006
3SaltsIBA
03/2013 - 01/2012
3CalciumIBA
04/2012 - 02/2005
3Sirolimus (Rapamycin)FDA Link
03/2010 - 07/2007
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2009 - 07/2007
3Phosphotransferases (Kinase)IBA
01/2009 - 02/2007
2Pharmaceutical PreparationsIBA
04/2022 - 10/2017
2FoscarnetFDA LinkGeneric
04/2022 - 02/2020
2MelatoninIBA
11/2021 - 01/2011
2Trastuzumab (Herceptin)FDA Link
07/2020 - 01/2009
2PolymersIBA
01/2020 - 05/2013
2GemcitabineFDA Link
10/2017 - 05/2013
2poly-N-isopropylacrylamideIBA
10/2017 - 05/2013
2Folic Acid (Vitamin M)FDA LinkGeneric
10/2017 - 04/2012
2Phosphates (Orthophosphate)IBA
01/2017 - 06/2015
2Peptides (Polypeptides)IBA
03/2015 - 05/2013
2GoldIBA
04/2014 - 04/2011
2TESIBA
08/2013 - 08/2011
2Glucose (Dextrose)FDA LinkGeneric
10/2012 - 04/2011
2TOR Serine-Threonine KinasesIBA
07/2012 - 03/2010
2Ceftriaxone (Ceftriaxon)FDA LinkGeneric
04/2012 - 01/2012
2Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
01/2012 - 06/2010
2MicellesIBA
04/2011 - 08/2010
2Angiotensin II Type 1 Receptor BlockersIBA
06/2007 - 02/2005
2CollagenIBA
06/2007 - 12/2003
2CytokinesIBA
01/2007 - 08/2006
2trandolapril (Mavik)FDA LinkGeneric
03/2006 - 02/2005
2CalpainIBA
03/2006 - 02/2005
2candesartanIBA
03/2006 - 02/2005
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2005 - 04/2003
2Vasopeptidase InhibitorsIBA
12/2003 - 04/2003
1nedaplatinIBA
02/2022

Therapy/Procedure

15Therapeutics
11/2021 - 06/2006
8Immunotherapy
08/2018 - 01/2014
4Drug Therapy (Chemotherapy)
05/2021 - 05/2013
4Ligation
07/2012 - 04/2003
2Combination Drug Therapy (Combination Chemotherapy)
02/2022 - 05/2013
2Precision Medicine
01/2020 - 01/2020
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
07/2018 - 12/2013
2Radiotherapy
10/2017 - 05/2013
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2017 - 01/2007
2Nephrectomy
01/2017 - 09/2014
2Cardiopulmonary Bypass (Heart-Lung Bypass)
09/2014 - 08/2006
2Aftercare (After-Treatment)
05/2013 - 05/2008
2Home Nursing (Nursing, Home)
05/2009 - 10/2006
1Hematopoietic Stem Cell Transplantation
04/2022